Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaMatrix
Sandvika, Norwaynovamatrix.biz ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NovaMatrix supplies ultrapure biopolymers such as alginates and hyaluronates for biomedical and pharmaceutical applications. Its products are used in commercially-available medical devices, clinical drug delivery, tissue engineering, and advanced biotechnologies, with established safety and efficacy track records in both preclinical and clinical research contexts[1][2][5][3].
- Therapeutic areas
- OtherDermatologyRheumatology
- Modalities
- Hydrogel-based drug delivery therapyCell therapyBiologic
- Industry
- Chemicals & Materials
02
Partnerships
Kikkoman Biochemifa Company (Japan, for sodium hyaluronate production)
Beyond the preview
Go deeper on NovaMatrix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NovaMatrix.